S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
66,000% upside on tiny biotech? (Ad)
Roku stock and the mother of all entry opportunities
AI powerhouse NVIDIA will hit $1000 soon
66,000% upside on tiny biotech? (Ad)
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
Rivian shares gets discounted; shares can move lower 
66,000% upside on tiny biotech? (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard
S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
66,000% upside on tiny biotech? (Ad)
Roku stock and the mother of all entry opportunities
AI powerhouse NVIDIA will hit $1000 soon
66,000% upside on tiny biotech? (Ad)
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
Rivian shares gets discounted; shares can move lower 
66,000% upside on tiny biotech? (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard
S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
66,000% upside on tiny biotech? (Ad)
Roku stock and the mother of all entry opportunities
AI powerhouse NVIDIA will hit $1000 soon
66,000% upside on tiny biotech? (Ad)
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
Rivian shares gets discounted; shares can move lower 
66,000% upside on tiny biotech? (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard
S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
66,000% upside on tiny biotech? (Ad)
Roku stock and the mother of all entry opportunities
AI powerhouse NVIDIA will hit $1000 soon
66,000% upside on tiny biotech? (Ad)
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
Rivian shares gets discounted; shares can move lower 
66,000% upside on tiny biotech? (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard

Regeneron Pharmaceuticals (REGN) News Today

$964.89
+12.05 (+1.26%)
(As of 02/22/2024 ET)
SourceHeadline
finanznachrichten.de logoRegeneron Pharmaceuticals, Inc.: Dupixent (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of COPD with Type 2 Inflammation
finanznachrichten.de - February 23 at 5:27 AM
MarketBeat logoRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Receives Consensus Rating of "Moderate Buy" from Brokerages
americanbankingnews.com - February 23 at 1:42 AM
marketbeat.com logoRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Receives Average Rating of "Moderate Buy" from Analysts
marketbeat.com - February 23 at 1:42 AM
globenewswire.com logoDupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of COPD with Type 2 Inflammation
globenewswire.com - February 23 at 1:00 AM
globenewswire.com logoPress Release: Dupixent® sBLA accepted for FDA Priority Review for treatment of COPD with type 2 inflammation
globenewswire.com - February 23 at 1:00 AM
ca.finance.yahoo.com logoREGN Feb 2024 957.500 put
ca.finance.yahoo.com - February 22 at 10:43 PM
finance.yahoo.com logoREGN Feb 2024 965.000 put
finance.yahoo.com - February 22 at 5:42 PM
finance.yahoo.com logoREGN Feb 2024 952.500 call
finance.yahoo.com - February 22 at 5:42 PM
marketbeat.com logoRegeneron Pharmaceuticals Q4 Earnings Transcript
marketbeat.com - February 22 at 7:01 AM
finanznachrichten.de logoRegeneron Pharmaceuticals, Inc.: Linvoseltamab BLA for Treatment of Relapsed/Refractory Multiple Myeloma Accepted for FDA Priority Review
finanznachrichten.de - February 21 at 9:41 PM
markets.businessinsider.com logoLinvoseltamab BLA for Treatment of Relapsed/Refractory Multiple Myeloma Accepted for FDA Priority Review
markets.businessinsider.com - February 21 at 4:40 PM
marketbeat.com logoRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Holdings Raised by Ontario Teachers Pension Plan Board
marketbeat.com - February 21 at 11:27 AM
fool.com logo2 No-Brainer Biotech Stocks to Buy Right Now
fool.com - February 21 at 10:00 AM
globenewswire.com logoLinvoseltamab BLA for Treatment of Relapsed/Refractory Multiple Myeloma Accepted for FDA Priority Review
globenewswire.com - February 21 at 7:00 AM
finance.yahoo.com logoREGN Mar 2024 1090.000 call
finance.yahoo.com - February 20 at 5:59 PM
finance.yahoo.com logoREGN Mar 2024 910.000 put
finance.yahoo.com - February 20 at 5:59 PM
marketbeat.com logoHealthcare of Ontario Pension Plan Trust Fund Grows Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
marketbeat.com - February 20 at 3:37 PM
finance.yahoo.com logoREGN Mar 2024 1010.000 call
finance.yahoo.com - February 20 at 12:59 PM
finance.yahoo.com logoREGN Mar 2024 820.000 put
finance.yahoo.com - February 20 at 12:59 PM
marketbeat.com logoNordea Investment Management AB Lowers Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
marketbeat.com - February 19 at 7:51 AM
finance.yahoo.com logoREGN Mar 2024 952.500 call
finance.yahoo.com - February 19 at 7:50 AM
finance.yahoo.com logoREGN Apr 2024 1005.000 call
finance.yahoo.com - February 19 at 7:50 AM
marketbeat.com logoPearl River Capital LLC Trims Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
marketbeat.com - February 18 at 10:57 AM
fool.com logo2 Top Growth Stocks to Buy With $1,000 Right Now
fool.com - February 18 at 10:23 AM
fool.com logo2 Top Growth Stocks to Buy With $1,000 Right Now
fool.com - February 18 at 12:45 AM
marketbeat.com logoInvesco Ltd. Has $611.75 Million Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
marketbeat.com - February 17 at 11:33 AM
finance.yahoo.com logoREGN Feb 2024 700.000 put
finance.yahoo.com - February 17 at 7:55 AM
finance.yahoo.com logoREGN Feb 2024 1000.000 call
finance.yahoo.com - February 17 at 1:54 AM
finance.yahoo.com logoREGN Feb 2024 930.000 put
finance.yahoo.com - February 17 at 1:54 AM
marketbeat.com logo5,668 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Purchased by RPg Family Wealth Advisory LLC
marketbeat.com - February 16 at 7:27 PM
finance.yahoo.com logoREGN Mar 2024 975.000 call
finance.yahoo.com - February 16 at 3:50 PM
au.finance.yahoo.com logoREGN Feb 2024 1010.000 call
au.finance.yahoo.com - February 16 at 10:50 AM
marketbeat.com logoRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Sees Large Increase in Short Interest
marketbeat.com - February 16 at 6:25 AM
globenewswire.com logoPress Release: Japan first in the world to approve Dupixent® for chronic spontaneous urticaria (CSU)
globenewswire.com - February 16 at 1:00 AM
globenewswire.com logoJapan First in the World to Approve Dupixent® (dupilumab) for Chronic Spontaneous Urticaria (CSU)
globenewswire.com - February 16 at 12:59 AM
marketbeat.com logoRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is Rhenman & Partners Asset Management AB's 4th Largest Position
marketbeat.com - February 15 at 7:34 PM
au.finance.yahoo.com logoREGN Feb 2024 1240.000 call
au.finance.yahoo.com - February 15 at 4:14 AM
ca.finance.yahoo.com logoREGN Jun 2025 690.000 put
ca.finance.yahoo.com - February 15 at 4:14 AM
seekingalpha.com logoRegeneron Pharmaceuticals, Inc. (REGN) Oppenheimer 34th Annual Healthcare Life Sciences Conference (Transcript)
seekingalpha.com - February 14 at 4:13 PM
marketbeat.com logoRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Acquired by Bank Julius Baer & Co. Ltd Zurich
marketbeat.com - February 14 at 3:44 PM
finance.yahoo.com logoPossible Bearish Signals With Regeneron Pharmaceuticals Insiders Disposing Stock
finance.yahoo.com - February 13 at 9:57 AM
marketbeat.com logoCornerstone Advisors LLC Reduces Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
marketbeat.com - February 13 at 9:54 AM
bizjournals.com logoRegeneron's planned Albany County expansion to receive tax breaks
bizjournals.com - February 12 at 6:56 PM
marketbeat.com logoDeutsche Bank AG Lowers Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
marketbeat.com - February 12 at 9:23 AM
marketbeat.com logoHighTower Advisors LLC Buys 818 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
marketbeat.com - February 11 at 7:02 AM
marketbeat.com logoRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Bought by Capstone Wealth Management Group LLC
marketbeat.com - February 10 at 11:16 AM
seekingalpha.com logoRegeneron Pharmaceuticals: Time To Change My Strategy After Encouraging Q4 2024
seekingalpha.com - February 10 at 9:34 AM
marketbeat.com logoInsider Selling: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) EVP Sells 1,000 Shares of Stock
marketbeat.com - February 9 at 6:58 PM
marketbeat.com logoSkandinaviska Enskilda Banken AB publ Has $62.89 Million Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
marketbeat.com - February 9 at 6:49 PM
marketbeat.com logoCodex Capital L.L.C. Has $5.10 Million Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
marketbeat.com - February 8 at 4:43 PM
Get Regeneron Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for REGN and its competitors with MarketBeat's FREE daily newsletter.



REGN Media Mentions By Week

REGN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

REGN
News Sentiment

0.58

0.48

Average
Medical
News Sentiment

REGN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

REGN Articles
This Week

30

13

REGN Articles
Average Week

Get Regeneron Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for REGN and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:REGN) was last updated on 2/23/2024 by MarketBeat.com Staff